1.
|
Shibutani S, Takeshita M and Grollman AP:
Insertion of specific bases during DNA synthesis past the
oxidation-damaged base 8-oxodG. Nature. 349:431–434. 1991.
View Article : Google Scholar : PubMed/NCBI
|
2.
|
Hussain SP, Hofseth LJ and Harris CC:
Radical causes of cancer. Nat Rev Cancer. 3:276–285. 2003.
View Article : Google Scholar : PubMed/NCBI
|
3.
|
Gasche C, Chang CL, Rhees J, Goel A, et
al: Oxidative stress increases frameshift mutations in human
colorectal cancer cells. Cancer Res. 61:7444–7448. 2001.PubMed/NCBI
|
4.
|
Zienolddiny S, Ryberg D and Haugen A:
Induction of microsatellite mutations by oxidative agents in human
lung cancer cell lines. Carcinogenesis. 21:1521–1526. 2000.
View Article : Google Scholar : PubMed/NCBI
|
5.
|
Markowitz S, Wang J, Myeroff L, et al:
Inactivation of the type II TGF-beta receptor in colon cancer cells
with microsatellite instability. Science. 268:1336–1338. 1995.
View Article : Google Scholar : PubMed/NCBI
|
6.
|
Sugimura T and Ushijima T: Genetic and
epigenetic alterations in carcinogenesis. Mutat Res. 462:235–246.
2000. View Article : Google Scholar : PubMed/NCBI
|
7.
|
Lim SO, Gu JM, Kim MS, et al: Epigenetic
changes induced by reactive oxygen species in hepatocellular
carcinoma: methylation of the E-cadherin promoter.
Gastroenterology. 135:2128–2140. 2008. View Article : Google Scholar : PubMed/NCBI
|
8.
|
Kang KA, Zhang R, Kim GY, Bae SC, et al:
Epigenetic changes induced by oxidative stress in colorectal cancer
cells: methylation of tumor suppressor RUNX3. Tumour Biol.
33:403–412. 2012. View Article : Google Scholar : PubMed/NCBI
|
9.
|
Lovatt M and Bijlmakers MJ: Stabilisation
of beta-catenin downstream of T cell receptor signalling. PLoS One.
5:e127942010. View Article : Google Scholar
|
10.
|
McManus EJ, Sakamoto K, Armit LJ, et al:
Role that phosphorylation of GSK3 plays in insulin and Wnt
signalling defined by knockin analysis. EMBO J. 24:1571–1583. 2005.
View Article : Google Scholar : PubMed/NCBI
|
11.
|
Fuchs SY, Ougolkov AV, Spiegelman VS and
Minamoto T: Oncogenic beta-catenin signaling networks in colorectal
cancer. Cell Cycle. 4:1522–1539. 2005. View Article : Google Scholar : PubMed/NCBI
|
12.
|
Bae SC and Choi JK: Tumor suppressor
activity of RUNX3. Oncogene. 23:4336–4340. 2004. View Article : Google Scholar : PubMed/NCBI
|
13.
|
Subramaniam MM, Chan JY, Yeoh GK, et al:
Molecular pathology of RUNX3 in human carcinogenesis. Biochim
Biophys Acta. 1796:315–331. 2009.PubMed/NCBI
|
14.
|
Li QL, Ito K, Sakakura C, et al: Causal
relationship between the loss of RUNX3 expression and gastric
cancer. Cell. 109:113–124. 2002. View Article : Google Scholar : PubMed/NCBI
|
15.
|
Chuang LS and Ito Y: RUNX3 is
multifunctional in carcinogenesis of multiple solid tumors.
Oncogene. 29:2605–2615. 2010. View Article : Google Scholar : PubMed/NCBI
|
16.
|
Chi XZ, Yang JO, Lee KY, et al: RUNX3
suppresses gastric epithelial cell growth by inducing
p21(WAF1/Cip1) expression. Mol Cell Biol. 25:8097–8107. 2005.
View Article : Google Scholar : PubMed/NCBI
|
17.
|
Yano T, Ito K, Fukamachi H, et al: The
RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells
undergoing transforming growth factor beta-induced apoptosis. Mol
Cell Biol. 26:4474–4488. 2006. View Article : Google Scholar : PubMed/NCBI
|
18.
|
Chang TL, Ito K, Ko TK, et al: Claudin-1
has tumor suppressive activity and is a direct target of RUNX3 in
gastric epithelial cells. Gastroenterology. 138:255–265. 2010.
View Article : Google Scholar : PubMed/NCBI
|
19.
|
Blau S, Rubistein A, Bass P, et al:
Differences in the reducing power along the rat GI tract: lower
antioxidant capacity of the colon. Mol Cell Biochem. 194:185–191.
1999. View Article : Google Scholar
|
20.
|
Benhar M, Engelberg D and Levitzki A: ROS,
stress-activated kinases and stress-signaling in cancer. EMBO Rep.
3:420–425. 2002. View Article : Google Scholar : PubMed/NCBI
|
21.
|
Skrzydlewska E, Sulkowski S, Koda M, et
al: Lipid peroxidation and antioxidant status in colorectal cancer.
World J Gastroenterol. 11:403–406. 2005. View Article : Google Scholar : PubMed/NCBI
|
22.
|
Chen JC, Huang KC and Lin WW: HMG-CoA
reductase inhibitors upregulate heme oxygenase-1 expression in
murine RAW264.7 macrophages via ERK, p38 MAPK and protein kinase G
pathways. Cell Signal. 18:32–39. 2006. View Article : Google Scholar : PubMed/NCBI
|
23.
|
Lin FC, Liu YP, Lai CH, et al:
RUNX3-mediated transcriptional inhibition of Akt suppresses
tumorigenesis of human gastric cancer cells. Oncogene.
31:4302–4316. 2012. View Article : Google Scholar : PubMed/NCBI
|
24.
|
Lee YJ, Jeong HY, Kim YB, et al: Reactive
oxygen species and PI3K/Akt signaling play key roles in the
induction of Nrf2-driven heme oxygenase-1 expression in
sulforaphane-treated human mesothelioma MSTO-211H cells. Food Chem
Toxicol. 50:116–123. 2012. View Article : Google Scholar
|
25.
|
Irani K: Oxidant signaling in vascular
cell growth, death, and survival: a review of the roles of reactive
oxygen species in smooth muscle and endothelial cell mitogenic and
apoptotic signaling. Circ Res. 87:179–183. 2000. View Article : Google Scholar : PubMed/NCBI
|
26.
|
Osaki M, Oshimura M and Ito H: PI3K-Akt
pathway: its functions and alterations in human cancer. Apoptosis.
9:667–676. 2004. View Article : Google Scholar : PubMed/NCBI
|
27.
|
Malumbres M and Barbacid M: Cell cycle,
CDKs and cancer: a changing paradigm. Nat Rev Cancer. 9:153–166.
2009. View
Article : Google Scholar : PubMed/NCBI
|
28.
|
Pradeep A, Sharma C, Sathyanarayana P, et
al: Gastrin-mediated activation of cyclin D1 transcription involves
beta-catenin and CREB pathways in gastric cancer cells. Oncogene.
23:3689–3699. 2004. View Article : Google Scholar : PubMed/NCBI
|
29.
|
Kang DH: Oxidative stress, DNA damage, and
breast cancer. AACN Clinical Issues. 13:540–549. 2002. View Article : Google Scholar : PubMed/NCBI
|
30.
|
Wang X, McCullough KD, Franke TF and
Holbrook NJ: Epidermal growth factor receptor-dependent Akt
activation by oxidative stress enhances cell survival. J Biol Chem.
275:14624–14631. 2000. View Article : Google Scholar : PubMed/NCBI
|
31.
|
Huang C, Li J, Ding M, et al: UV Induces
phosphorylation of protein kinase B (Akt) at Ser-473 and Thr-308 in
mouse epidermal Cl 41 cells through hydrogen peroxide. J Biol Chem.
276:40234–40240. 2001. View Article : Google Scholar : PubMed/NCBI
|
32.
|
Manning BD and Cantley LC: AKT/PKB
signaling: navigating downstream. Cell. 129:1261–1274. 2007.
View Article : Google Scholar : PubMed/NCBI
|
33.
|
Plas DR and Thompson CB: Akt-dependent
transformation: there is more to growth than just surviving.
Oncogene. 24:7435–7442. 2005. View Article : Google Scholar : PubMed/NCBI
|
34.
|
Los M, Maddika S, Erb B and
Schulze-Osthoff K: Switching Akt: from survival signaling to deadly
response. Bioessays. 31:492–495. 2009. View Article : Google Scholar : PubMed/NCBI
|
35.
|
Oki E, Baba H, Tokunaga E, et al: Akt
phosphorylation associates with LOH of PTEN and leads to
chemoresistance for gastric cancer. Int J Cancer. 117:376–380.
2005. View Article : Google Scholar : PubMed/NCBI
|
36.
|
Li VS, Wong CW, Chan TL, et al: Mutations
of PIK3CA in gastric adenocarcinoma. BMC Cancer. 5:292005.
View Article : Google Scholar : PubMed/NCBI
|
37.
|
Soung YH, Lee JW, Nam SW, et al:
Mutational analysis of AKT1, AKT2 and AKT3 genes in common human
carcinomas. Oncology. 70:285–289. 2006. View Article : Google Scholar : PubMed/NCBI
|
38.
|
Dihlmann S, Kloor M, Fallsehr C and von
Knebel Doeberitz M: Regulation of AKT1 expression by
beta-catenin/Tcf/Lef signaling in colorectal cancer cells.
Carcinogenesis. 26:1503–1512. 2005. View Article : Google Scholar : PubMed/NCBI
|
39.
|
Misra UK and Pizzo SV: Upregulation of
AKT1 protein expression in forskolin-stimulated macrophage:
evidence from ChIP analysis that CREB binds to and activates the
AKT1 promoter. J Cell Biochem. 100:1022–1033. 2007. View Article : Google Scholar : PubMed/NCBI
|
40.
|
Fahrner JA, Eguchi S, Herman JG and Baylin
SB: Dependence of histone modifications and gene expression on DNA
hypermethylation in cancer. Cancer Res. 62:7213–7218.
2002.PubMed/NCBI
|
41.
|
Li QL, Kim HR, Kim WJ, et al:
Transcriptional silencing of the RUNX3 gene by CpG hypermethylation
is associated with lung cancer. Biochem Biophys Res Commun.
314:223–228. 2004. View Article : Google Scholar : PubMed/NCBI
|
42.
|
Di Vinci A, Infusini E, Nigro S, et al:
Intratumor distribution of 1p deletions in human colorectal
adenocarcinoma is commonly homogeneous: indirect evidence of early
involvement in colorectal tumorigenesis. Cancer. 83:415–422.
1998.
|
43.
|
Di Vinci A, Infusini E, Peveri C, et al:
Correlation between 1p deletions and aneusomy in human colorectal
adenomas. Int J Cancer. 75:45–50. 1998.PubMed/NCBI
|
44.
|
Tanaka K, Yanoshita R, Konishi M, et al:
Suppression of tumourigenicity in human colon carcinoma cells by
introduction of normal chromosome 1p36 region. Oncogene.
8:2253–2258. 1993.
|
45.
|
Praml C, Finke LH, Herfarth C, et al:
Deletion mapping defines different regions in 1p34.2-pter that may
harbor genetic information related to human colorectal cancer.
Oncogene. 11:1357–1362. 1995.
|
46.
|
Durst KL and Hiebert SW: Role of RUNX
family members in transcriptional repression and gene silencing.
Oncogene. 23:4220–4224. 2004. View Article : Google Scholar : PubMed/NCBI
|
47.
|
Ito Y: RUNX genes in development and
cancer: regulation of viral gene expression and the discovery of
RUNX family genes. Adv Cancer Res. 99:33–76. 2008. View Article : Google Scholar : PubMed/NCBI
|